Eton Pharmaceuticals, Inc. (ETON)
55.36
+3.38
(+6.50%)
USD |
NASDAQ |
Oct 02, 16:00
55.37
+0.01
(+0.02%)
After-Hours: 20:00
Eton Pharmaceuticals Profit Margin (Quarterly) : 30.80% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.80% |
| March 31, 2026 | 6.40% |
| December 31, 2025 | 6.97% |
| September 30, 2025 | -8.58% |
| June 30, 2025 | -13.66% |
| March 31, 2025 | -9.10% |
| December 31, 2024 | -5.13% |
| September 30, 2024 | 6.07% |
| June 30, 2024 | -33.51% |
| March 31, 2024 | -10.18% |
| December 31, 2023 | -30.85% |
| September 30, 2023 | -8.24% |
| June 30, 2023 | 38.00% |
| March 31, 2023 | -50.15% |
| December 31, 2022 | 10.73% |
| Date | Value |
|---|---|
| September 30, 2022 | -94.59% |
| June 30, 2022 | -21.17% |
| March 31, 2022 | -244.9% |
| December 31, 2021 | 17.05% |
| September 30, 2021 | -786.3% |
| June 30, 2021 | -65.73% |
| March 31, 2021 | 43.00% |
| December 31, 2020 | -9.49K% |
| September 30, 2020 | |
| June 30, 2020 | -23.65K% |
| March 31, 2020 | -9.14K% |
| December 31, 2019 | -587.4% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -1.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | -1.64% |
| Elite Pharmaceuticals, Inc. | 18.27% |
| Daré Bioscience, Inc. | -1.59K% |
| Liquidia Corp. | 43.52% |
| ANI Pharmaceuticals, Inc. | 8.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 42.17% |
| Return on Assets | 12.40% |
| Return on Invested Capital | 20.90% |
| Gross Profit Margin (Quarterly) | 67.61% |
| Operating Margin (Quarterly) | 34.04% |
| Return on Net Operating Assets | 18.28% |